[1]
|
Shen, T., Liu, Y., Shang, J., et al. (2019) Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gas-troenterology, 156, 2230-2241. https://doi.org/10.1053/j.gastro.2019.02.002
|
[2]
|
Stephens, C., Lucena, M.I. and Andrade, R.J. (2021) Genetic Risk Factors in the Development of Idiosyncratic Drug-Induced Liver Injury. Expert Opinion on Drug Metabolism & Toxicology, 17, 153-169.
https://doi.org/10.1080/17425255.2021.1854726
|
[3]
|
吴佳栩, 江锋, 薛婧. 中医药治疗药物性肝损伤的现状与思考[J]. 中西医结合肝病杂志, 2021, 31(12): 1119-1122.
|
[4]
|
于乐成, 茅益民, 陈成伟. 药物性肝损伤诊治指南[J]. 实用肝脏病杂志, 2017, 20(2): 257-274.
|
[5]
|
Zhang, Y., Gao, H., Zhang, Y., Shao, Y.-M., Zhang, R.-H. and Wen, X.-Y. (2022) Correlation between Serum Cytokines and Clinicopathological Features in Patients with Drug-Induced Liver Injury. Frontiers in Pharmacology, 13, Article 1070802. https://doi.org/10.3389/fphar.2022.1070802
|
[6]
|
Bjornsson, E.S. (2021) Clinical Management of Patients with Drug-Induced Liver Injury (DILI). United European Gastroenterology Journal, 9, 781-786. https://doi.org/10.1002/ueg2.12113
|
[7]
|
Umbaugh, D.S. and Jaeschke, H. (2021) Biomarkers of Drug-Induced Liver Injury: A Mechanistic Perspective through Acetaminophen Hepatotoxicity. Expert Review of Gastroenterology & Hepatology, 15, 363-375.
https://doi.org/10.1080/17474124.2021.1857238
|
[8]
|
Bonkovsky, H.L., Barnhart, H.X., Foureau, D.M., et al. (2018) Cytokine Profiles in Acute Liver Injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group. PLOS ONE, 13, e206389. https://doi.org/10.1371/journal.pone.0206389
|
[9]
|
Steuerwald, N.M., Foureau, D.M., Norton, H.J., et al. (2013) Profiles of Serum Cytokines in Acute Drug-Induced Liver Injury and Their Prognostic Significance. PLOS ONE, 8, e81974. https://doi.org/10.1371/journal.pone.0081974
|
[10]
|
张雨, 邵玥明, 秦婷婷, 等. 细胞因子在药物性肝损伤中的研究现状及应用价值[J]. 临床肝胆病杂志, 2020, 36(8): 1883-1886.
|
[11]
|
Ali, S.E., Waddington, J.C., Park, B.K., et al. (2020) Definition of the Chemical and Immunological Signals Involved in Drug-Induced Liver Injury. Chem-ical Research in Toxicology, 33, 61-76.
https://doi.org/10.1021/acs.chemrestox.9b00275
|
[12]
|
Kumar, N., Surani, S., Udeani, G., et al. (2021) Drug-Induced Liver Injury and Prospect of Cytokine Based Therapy: A Focus on IL-2 Based Therapies. Life Sciences, 278, Article ID: 119544. https://doi.org/10.1016/j.lfs.2021.119544
|
[13]
|
Antunes, G., Evans, S.A., Lordan, J.L., et al. (2002) Systemic Cytokine Levels in Community-Acquired Pneumonia and Their Association with Disease Severity. European Respiratory Journal, 20, 990-995.
https://doi.org/10.1183/09031936.02.00295102
|
[14]
|
Hart, J.P., Broadwater, G., Rabbani, Z., et al. (2005) Cytokine Profiling for Prediction of Symptomatic Radiation-Induced Lung Injury. International Journal of Radiation Oncolo-gy-Biology-Physics, 63, 1448-1454.
https://doi.org/10.1016/j.ijrobp.2005.05.032
|
[15]
|
Kellum, J.A., Kong, L., Fink, M.P., et al. (2007) Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Archives of Internal Medicine, 167, 1655-1663. https://doi.org/10.1001/archinte.167.15.1655
|
[16]
|
Kakisaka, K. and Takikawa, Y. (2014) Elevation of Serum Cyto-kines Preceding Elevation of Liver Enzymes in a Case of Drug-Induced Liver Injury. Hepatology Research, 44, E284-E289. https://doi.org/10.1111/hepr.12253
|
[17]
|
Kobayashi, M., Higuchi, S., Mizuno, K., Tsuneyama, K., Fu-kami, T., Nakajima, M. and Yokoi, T. (2010) Interleukin-17 Is Involved in Alpha-Naphthylisothiocyanate-Induced Liver Injury in Mice. Toxicology, 275, 50-57.
https://doi.org/10.1016/j.tox.2010.05.011
|
[18]
|
Kobayashi, M., Higuchi, S., Ide, M., Nishikawa, S., Fukami, T., Nakajima, M. and Yokoi, T. (2012) Th2 Cytokine-Mediated Methimazole-Induced Acute Liver Injury in Mice. Journal of Applied Toxicology, 32, 823-833.
https://doi.org/10.1002/jat.2731
|
[19]
|
朱晓文, 孙瑜, 戴新征, 等. 细胞因子水平对药物性肝损伤患者肝功能恢复的预测价值[J]. 江苏医药, 2021, 47(12): 1235-1237.
|
[20]
|
王兰, 杨瑞宁. IL-9、IL-10在免疫性肝损伤中的作用及临床意义[J]. 检验医学与临床, 2017, 14(20): 3011-3014.
|
[21]
|
Molina, M.F., Abdelnabi, M.N., Fabre, T., et al. (2019) Type 3 Cytokines in Liver Fibrosis and Liver Cancer. Cytokine, 124, Article ID: 154497. https://doi.org/10.1016/j.cyto.2018.07.028
|
[22]
|
Laverty, H.G., Antoine, D.J., Benson, C., Chaponda, M., Williams, D. and Park, B.K. (2010) The Potential of Cytokines as Safety Biomarkers for Drug-Induced Liver Injury. European Journal of Clinical Pharmacology, 66, 961-976.
https://doi.org/10.1007/s00228-010-0862-x
|
[23]
|
Sun, Y., Gu, J., Liu, R., Zhou, H., Lu, L., Dai, X. and Qian, X. (2019) IL-2/IL-6 Ratio Correlates with Liver Function and Recovery in Acute Liver Injury Patients. APMIS, 127, 468-474. https://doi.org/10.1111/apm.12944
|
[24]
|
Xiang, X., Feng, D., Hwang, S., et al. (2020) Interleukin-22 Ameliorates Acute-on-Chronic Liver Failure by Reprogramming Impaired Regeneration Pathways in Mice. Journal of Hepatology, 72, 736-745.
https://doi.org/10.1016/j.jhep.2019.11.013
|
[25]
|
Hassan, A. and Fontana, R.J. (2019) The Diagnosis and Manage-ment of Idiosyncratic Drug-Induced Liver Injury. Liver International, 39, 31-41. https://doi.org/10.1111/liv.13931
|
[26]
|
Xie, Z., Chen, E., Ouyang, X., et al. (2019) Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury. Journal of Proteome Research, 18, 2514-2524.
https://doi.org/10.1021/acs.jproteome.9b00047
|
[27]
|
Mishra, J., Simonsen, R. and Kumar, N. (2019) Intestinal Breast Cancer Resistance Protein (BCRP) Requires Janus Kinase 3 Activity for Drug Efflux and Barrier Functions in Obesity. Journal of Biological Chemistry, 294, 18337-18348.
https://doi.org/10.1074/jbc.RA119.007758
|